1 Market Overview 1.1 Selumetinib Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Selumetinib Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 10 mg 1.2.3 25 mg 1.3 Market Analysis by Application 1.3.1 Overview: Global Selumetinib Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Overview of Global Selumetinib Market 1.4.1 Global Selumetinib Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AstraZeneca 2.1.1 AstraZeneca Details 2.1.2 AstraZeneca Major Business 2.1.3 AstraZeneca SWOT Analysis 2.1.4 AstraZeneca Product and Services 2.1.5 AstraZeneca Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Merck 2.2.1 Merck Details 2.2.2 Merck Major Business 2.2.3 Merck SWOT Analysis 2.2.4 Merck Product and Services 2.2.5 Merck Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Selumetinib Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Selumetinib Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Selumetinib Manufacturer Market Share in 2019 3.3.2 Top 6 Selumetinib Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Selumetinib Sales, Revenue and Market Share by Regions 4.1.1 Global Selumetinib Sales and Market Share by Regions (2015-2020) 4.1.2 Global Selumetinib Revenue and Market Share by Regions (2015-2020) 4.2 North America Selumetinib Sales and Growth Rate (2015-2020) 4.3 Europe Selumetinib Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Selumetinib Sales and Growth Rate (2015-2020) 4.5 South America Selumetinib Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Selumetinib Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Selumetinib Sales, Revenue and Market Share by Country 5.1.1 North America Selumetinib Sales and Market Share by Country (2015-2020) 5.1.2 North America Selumetinib Revenue and Market Share by Country (2015-2020) 5.2 United States Selumetinib Sales and Growth Rate (2015-2020) 5.3 Canada Selumetinib Sales and Growth Rate (2015-2020) 5.4 Mexico Selumetinib Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Selumetinib Sales, Revenue and Market Share by Country 6.1.1 Europe Selumetinib Sales and Market Share by Country (2015-2020) 6.1.2 Europe Selumetinib Revenue and Market Share by Country (2015-2020) 6.2 Germany Selumetinib Sales and Growth Rate (2015-2020) 6.3 UK Selumetinib Sales and Growth Rate (2015-2020) 6.4 France Selumetinib Sales and Growth Rate (2015-2020) 6.5 Russia Selumetinib Sales and Growth Rate (2015-2020) 6.6 Italy Selumetinib Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Selumetinib Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Selumetinib Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Selumetinib Revenue and Market Share by Regions (2015-2020) 7.2 China Selumetinib Sales and Growth Rate (2015-2020) 7.3 Japan Selumetinib Sales and Growth Rate (2015-2020) 7.4 Korea Selumetinib Sales and Growth Rate (2015-2020) 7.5 India Selumetinib Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Selumetinib Sales and Growth Rate (2015-2020) 7.7 Australia Selumetinib Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Selumetinib Sales, Revenue and Market Share by Country 8.1.1 South America Selumetinib Sales and Market Share by Country (2015-2020) 8.1.2 South America Selumetinib Revenue and Market Share by Country (2015-2020) 8.2 Brazil Selumetinib Sales and Growth Rate (2015-2020) 8.3 Argentina Selumetinib Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Selumetinib Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Selumetinib Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Selumetinib Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Selumetinib Sales and Growth Rate (2015-2020) 9.3 Turkey Selumetinib Sales and Growth Rate (2015-2020) 9.4 Egypt Selumetinib Sales and Growth Rate (2015-2020) 9.5 South Africa Selumetinib Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Selumetinib Sales and Market Share by Type (2015-2020) 10.2 Global Selumetinib Revenue and Market Share by Type (2015-2020) 10.3 Global Selumetinib Price by Type (2015-2020) 11 Global Selumetinib Market Segment by Application 11.1 Global Selumetinib Sales Market Share by Application (2015-2020) 11.2 Global Selumetinib Revenue Market Share by Application (2015-2020) 11.3 Global Selumetinib Price by Application (2015-2020) 12 Market Forecast 12.1 Global Selumetinib Sales, Revenue and Growth Rate (2021-2025) 12.2 Selumetinib Market Forecast by Regions (2021-2025) 12.2.1 North America Selumetinib Market Forecast (2021-2025) 12.2.2 Europe Selumetinib Market Forecast (2021-2025) 12.2.3 Asia-Pacific Selumetinib Market Forecast (2021-2025) 12.2.4 South America Selumetinib Market Forecast (2021-2025) 12.2.5 Middle East & Africa Selumetinib Market Forecast (2021-2025) 12.3 Selumetinib Market Forecast by Type (2021-2025) 12.3.1 Global Selumetinib Sales Forecast by Type (2021-2025) 12.3.2 Global Selumetinib Market Share Forecast by Type (2021-2025) 12.4 Selumetinib Market Forecast by Application (2021-2025) 12.4.1 Global Selumetinib Sales Forecast by Application (2021-2025) 12.4.2 Global Selumetinib Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Selumetinib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Selumetinib by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Selumetinib Market Size and Growth Estimation in Various Scenarios in 2020 Table 4. Global Selumetinib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 5. Market Opportunities in Next Few Years Table 6. Market Risks Analysis Table 7. Market Drivers Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors Table 9. AstraZeneca Selumetinib Major Business Table 10. AstraZeneca Selumetinib Total Revenue (USD Million) (2018-2019) Table 11. AstraZeneca SWOT Analysis Table 12. AstraZeneca Selumetinib Product and Services Table 13. AstraZeneca Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 14. Merck Basic Information, Manufacturing Base and Competitors Table 15. Merck Selumetinib Major Business Table 16. Merck Selumetinib Total Revenue (USD Million) (2018-2019) Table 17. Merck SWOT Analysis Table 18. Merck Selumetinib Product and Services Table 19. Merck Selumetinib Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 20. Global Selumetinib Sales by Manufacturer (2018-2019) (K Units) Table 21. Global Selumetinib Revenue by Manufacturer (2018-2019) (USD Million) Table 22. Global Selumetinib Sales by Regions (2015-2020) (K Units) Table 23. Global Selumetinib Sales Market Share by Regions (2015-2020) Table 24. Global Selumetinib Revenue by Regions (2015-2020) (USD Million) Table 25. North America Selumetinib Sales by Countries (2015-2020) (K Units) Table 26. North America Selumetinib Sales Market Share by Countries (2015-2020) Table 27. North America Selumetinib Revenue by Countries (2015-2020) (USD Million) Table 28. North America Selumetinib Revenue Market Share by Countries (2015-2020) Table 29. Europe Selumetinib Sales by Countries (2015-2020) (K Units) Table 30. Europe Selumetinib Sales Market Share by Countries (2015-2020) Table 31. Europe Selumetinib Revenue by Countries (2015-2020) (USD Million) Table 32. Asia-Pacific Selumetinib Sales by Regions (2015-2020) (K Units) Table 33. Asia-Pacific Selumetinib Sales Market Share by Regions (2015-2020) Table 34. Asia-Pacific Selumetinib Revenue by Regions (2015-2020) (USD Million) Table 35. South America Selumetinib Sales by Countries (2015-2020) (K Units) Table 36. South America Selumetinib Sales Market Share by Countries (2015-2020) Table 37. South America Selumetinib Revenue by Countries (2015-2020) (USD Million) Table 38. South America Selumetinib Revenue Market Share by Countries (2015-2020) Table 39. Middle East & Africa Selumetinib Sales by Countries (2015-2020) (K Units) Table 40. Middle East & Africa Selumetinib Sales Market Share by Countries (2015-2020) Table 41. Middle East & Africa Selumetinib Revenue by Countries (2015-2020) (USD Million) Table 42. Middle East & Africa Selumetinib Revenue Market Share by Countries (2015-2020) Table 43. Global Selumetinib Sales by Type (2015-2020) (K Units) Table 44. Global Selumetinib Sales Share by Type (2015-2020) Table 45. Global Selumetinib Revenue by Type (2015-2020) (USD Million) Table 46. Global Selumetinib Revenue Share by Type (2015-2020) Table 47. Global Selumetinib Sales by Application (2015-2020) (K Units) Table 48. Global Selumetinib Sales Share by Application (2015-2020) Table 49. Global Selumetinib Sales Forecast by Regions (2021-2025) (K Units) Table 50. Global Selumetinib Market Share Forecast by Regions (2021-2025) Table 51. Global Selumetinib Sales Forecast by Type (2021-2025) (K Units) Table 52. Global Selumetinib Market Share Forecast by Type (2021-2025) Table 53. Global Selumetinib Sales Forecast by Application (2021-2025) Table 54. Global Selumetinib Market Share Forecast by Application (2021-2025) Table 55. Direct Channel Pros & Cons Table 56. Indirect Channel Pros & Cons Table 57. Distributors/Traders/ Dealers List List of Figures Figure 1. Selumetinib Picture Figure 2. Global Sales Market Share of Selumetinib by Type in 2019 Figure 3. 10 mg Picture Figure 4. 25 mg Picture Figure 5. Selumetinib Sales Market Share by Application in 2019 Figure 6. Hospitals Picture Figure 7. Clinics Picture Figure 8. Others Picture Figure 9. Global Selumetinib Market Status and Outlook (2015-2025) (USD Million) Figure 10. United States Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 11. Canada Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 12. Mexico Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 13. Germany Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 14. France Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 15. UK Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 16. Russia Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 17. Italy Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 18. China Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 19. Japan Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 20. Korea Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 21. India Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 22. Southeast Asia Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 23. Australia Selumetinib Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 24. Brazil Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 25. Egypt Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 26. Saudi Arabia Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 27. South Africa Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 28. Turkey Selumetinib Revenue (Value) and Growth Rate (2015-2025) Figure 29. Global Selumetinib Sales Market Share by Manufacturer in 2019 Figure 30. Global Selumetinib Revenue Market Share by Manufacturer in 2019 Figure 31. Top 3 Selumetinib Manufacturer (Revenue) Market Share in 2019 Figure 32. Top 6 Selumetinib Manufacturer (Revenue) Market Share in 2019 Figure 33. Key Manufacturer Market Share Trend Figure 34. Global Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 35. Global Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 36. Global Selumetinib Revenue Market Share by Regions (2015-2020) Figure 37. Global Selumetinib Revenue Market Share by Regions in 2018 Figure 38. North America Selumetinib Sales and Growth Rate (2015-2020) Figure 39. Europe Selumetinib Sales and Growth Rate (2015-2020) Figure 40. Asia-Pacific Selumetinib Sales and Growth Rate (2015-2020) Figure 41. South America Selumetinib Sales and Growth Rate (2015-2020) Figure 42. Middle East & Africa Selumetinib Sales and Growth Rate (2015-2020) Figure 43. North America Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 44. North America Selumetinib Sales Market Share by Countries (2015-2020) Figure 45. North America Selumetinib Sales Market Share by Countries in 2018 Figure 46. North America Selumetinib Revenue Market Share by Countries (2015-2020) (USD Million) Figure 47. North America Selumetinib Revenue Market Share by Countries in 2018 Figure 48. United States Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 49. Canada Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 50. Mexico Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 51. Europe Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 52. Europe Selumetinib Revenue Market Share by Countries (2015-2020) Figure 53. Europe Selumetinib Revenue Market Share by Countries in 2019 Figure 54. Germany Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 55. UK Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 56. France Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 57. Russia Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 58. Italy Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 59. Asia-Pacific Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 60. Asia-Pacific Selumetinib Sales Market Share by Regions 2019 Figure 61. Asia-Pacific Selumetinib Revenue Market Share by Regions 2019 Figure 62. China Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 63. Japan Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 64. Korea Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 65. India Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 66. Southeast Asia Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 67. South America Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 68. South America Selumetinib Sales Market Share by Countries in 2019 Figure 69. South America Selumetinib Revenue Market Share by Countries in 2019 Figure 70. Brazil Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 71. Argentina Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 72. Middle East and Africa Selumetinib Revenue and Growth Rate (2015-2020) (USD Million) Figure 73. Middle East and Africa Selumetinib Sales Market Share by Countries in 2019 Figure 74. Middle East and Africa Selumetinib Revenue Market Share by Countries (2015-2020) Figure 75. Middle East and Africa Selumetinib Revenue Market Share by Countries in 2019 Figure 76. Saudi Arabia Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 77. Egypt Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 78. Turkey Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 79. South Africa Selumetinib Sales and Growth Rate (2015-2020) (K Units) Figure 80. Global Selumetinib Sales and Growth Rate (2021-2025) (K Units) Figure 81. Global Selumetinib Revenue and Growth Rate (2021-2025) (USD Million) Figure 82. North America Sales Selumetinib Market Forecast (2021-2025) (K Units) Figure 83. Europe Sales Selumetinib Market Forecast (2021-2025) (K Units) Figure 84. Asia-Pacific Sales Selumetinib Market Forecast (2021-2025) (K Units) Figure 85. South America Sales Selumetinib Market Forecast (2021-2025) (K Units) Figure 86. Middle East & Africa Sales Selumetinib Market Forecast (2021-2025) (K Units) Figure 87. Sales Channel: Direct Channel vs Indirect Channel

AstraZeneca Merck